中原证券股份有限公司关于立中四通轻合金集团股份有限公司 部分募集资金投资项目延期的核查意见 中原证券股份有限公司（以下简称"中原证券"或"独立财务顾问"）作为 立中四通轻合金集团股份有限公司（以下简称"公司"或"立中集团"）发行股 份购买资产并募集配套资金的独立财务顾问，根据《上市公司募集资金监管规则》 《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等有关规定， 就公司将"年产 150 万只绿色超轻质铝合金车轮智慧生产线项目"达到预定可使用状态日期由 2025 年 6 月 30 日延期至 2025 年 12 月 31 日相关事项进行了核查，核查情况及核查意 见如下： 一、募集资金基本情况 经中国证监会核发的《关于同意河北四通新型金属材料股份有限公司发行股 份购买资产并募集配套资金注册的批复》（证监许可〔2021〕879 号）同意注册， 立中集团于 2021 年 9 月 3 日向特定对象发行人民币普通股（A 股）17,203,107 股（以下简称"本次发行"），每股发行价格为人民币 18.02 元，募集资金总额 为人民币 309,999,988. ...

二、募投项目整体情况 根据《公司向特定对象发行股票募集说明书》，公司前述募集资金扣除发行 费用后，用于以下四个项目： 单位：万元 | 募集资金投资项目 | | 投资总额 | | 募集资金承诺投资金额 | | | --- | --- | --- | --- | --- | --- | | 9.7 年产 | 亿米高档拉链配套织带搬迁及服饰辅料技 | | | | | | 改项目（一期） | | | | | | | 年产 2.2 亿米高档拉链扩建项目 | 34,620.00 32,760.00 | | | | | | 越南服装辅料生产项目 | 44,640.00 30,240.00 | | | | | | 补充流动资金 | 14,540.00 13,179.51 | | | | | | 总计 | 141,260.00 118,179.51 | | | | | | 三、本次拟调整的募投项目实施情况及延期调整的原因 | | | | | | | 本次拟调整的募投项目为"年产 2.2 | 亿米高档拉链扩建项目"，总投资 | | | | | | 以募集资金投入 32,760.00 | 万元；实施地为公司临海大洋工业园和邵家渡工 ...

Group 1 - The company announced a cash dividend distribution of 0.15 yuan per share for the fiscal year 2024, approved at the annual shareholders' meeting on June 25, 2025 [2][4] - The total cash dividend distribution amounts to approximately 141.13 million yuan, based on a total share capital of 940,996,515 shares, excluding shares held in the repurchase account [4][6] - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the record date [3][4] Group 2 - The company plans to postpone the completion dates for two fundraising investment projects: the "Jixi Branch Phase III Construction Project" to August 2026 and the "Traditional Chinese Medicine Material Processing Project" to October 2026 [11][22] - The postponement is due to external environmental factors affecting project progress, and the company aims to enhance the quality of the investment projects [22][25] - The board of directors approved the postponement during the meeting held on August 11, 2025, and the decision will be submitted for approval at the upcoming shareholders' meeting [26][36] Group 3 - The company intends to provide a guarantee for its wholly-owned subsidiary, Heilongjiang Zhenbaodao Medical Trade Co., Ltd., for bank financing up to 400 million yuan [29][30] - The guarantee is deemed necessary to support the subsidiary's operational needs, with the board considering the risk to be manageable [35][36] - The total amount of external guarantees provided by the company is 1.791 billion yuan, which accounts for 22.96% of the latest audited net assets [37]

Group 1 - The core point of the announcement is the approval of the extension of a fundraising investment project without changing the total investment amount or the purpose of the funds [1][2] - The project in question is the construction of a special polymer material production facility with an annual capacity of 45,000 tons [1] - The decision was made during the seventh meeting of the fifth supervisory board, which was held on August 1, 2025, with all three supervisors present [1][2] Group 2 - The vote on the extension proposal resulted in 3 votes in favor, with no votes against or abstentions [2] - The company assures that the extension does not negatively impact the implementation of the fundraising project or the interests of shareholders [1] - The announcement also complies with relevant regulations from the China Securities Regulatory Commission and the Shenzhen Stock Exchange regarding the management of raised funds [1]

Group 1 - The company held its fifth board meeting on August 1, 2025, with all seven directors present, and the meeting was chaired by the chairman Wu Xian [1][2] - The board approved the proposal to postpone the fundraising project for the annual production of 45,000 tons of special polymer materials, which will not affect the company's current operations or shareholder interests [2][3] - The board also approved amendments to the company's articles of association to enhance governance structure and operational standards, which will be submitted for shareholder approval [3][4] Group 2 - The company revised and established several governance systems to promote standardized operations and improve internal management mechanisms, with unanimous approval from the board [4][5] - A three-year shareholder return plan for 2025-2027 was approved to establish a scientific and stable return mechanism for shareholders, which will also require shareholder approval [5][6] - The board agreed not to hold a shareholder meeting immediately after this board meeting, with plans to notify shareholders later regarding the meeting [5][6]

Core Points - Zhejiang Huahai Pharmaceutical Co., Ltd. has announced a delay in the "Formulation Digital Intelligent Manufacturing Construction Project" to December 2026, as approved by the board of directors on July 24, 2025 [1][4] - The delay only involves adjustments to the project timeline and does not change the use of raised funds or negatively impact the company's normal operations or shareholder interests [1][4][5] - The total amount raised from the issuance of shares was approximately CNY 600 million, with a net amount of approximately CNY 582 million after deducting issuance costs [1][2] Fundraising Overview - The company raised CNY 599,999,994.54 by issuing 41,152,263 shares at a price of CNY 14.58 per share, with net proceeds of CNY 582,319,365.51 after deducting issuance costs [1][2] - The funds are allocated to two main projects: the "Formulation Digital Intelligent Manufacturing Construction Project" and working capital, with total planned investments of CNY 172,274.12 million [2] Project Delay Details - The original completion date for the "Formulation Digital Intelligent Manufacturing Construction Project" was set for July 2025, now postponed to December 2026 due to the project's large scale and external factors [3] - The project aims to integrate various information systems to create a fully automated production line with a designed capacity of 15 billion tablets per year [3] Impact of Delay - The delay is a strategic decision based on objective project conditions and will not materially affect the implementation of the project or the company's operations [4][5] - The company emphasizes that the delay does not involve changes to the investment content, purpose, total amount, or implementation entity of the project [4][5] Approval Process - The delay was approved through a series of meetings, including the board of directors and independent directors, and does not require shareholder approval [4][5][6]

Summary of Key Points Core Viewpoint - The company, Shenzhen Minglida Precision Technology Co., Ltd., has decided to postpone certain fundraising investment projects due to market changes and operational needs, reallocating part of the raised funds to a new project in Mexico [1][10]. Group 1: Fundraising Overview - The company issued 10 million convertible bonds with a total face value of 1 billion yuan, netting approximately 991.61 million yuan after deducting issuance costs [1]. - The funds are managed in a dedicated account with strict regulatory oversight, ensuring compliance with relevant laws and regulations [5][11]. Group 2: Investment Projects - The original investment projects included the construction of precision component production bases in Anhui and Jiangxi, and a smart manufacturing project for key components [3]. - The company plans to redirect 45 million yuan (45% of total raised funds) from the postponed projects to a new project for constructing a precision component production base for electric vehicles in Mexico [4][10]. Group 3: Project Postponement Details - The project for the Jiangxi precision component production base will experience delays in reaching its operational status due to various market and operational factors [9][10]. - The postponement does not alter the investment amounts or project content, ensuring no adverse impact on shareholder interests [10][12]. Group 4: Compliance and Oversight - The company has followed necessary procedures for the project postponement, receiving approval from both the board of directors and the supervisory board [11][12]. - The sponsor, Guotai Junan Securities, has confirmed that the postponement complies with regulatory requirements and does not harm the company's or shareholders' interests [12].

Group 1 - The company held a meeting on July 18, 2025, with all three supervisors present, and the meeting was convened in accordance with relevant laws and regulations [1][2] - The meeting approved a proposal to postpone certain fundraising investment projects, which the supervisory board deemed a prudent decision based on the company's development and current circumstances [1][2] - The decision aligns with the regulations set forth in the "Regulations on the Supervision of Fundraising by Listed Companies" and other relevant guidelines [1]

Core Viewpoint - The company has announced a delay in the completion date of its precision structural components production base project in Jiangxi, extending it from August 2025 to August 2026 due to comprehensive considerations of current business operations and project implementation needs [1] Group 1 - The second meeting of the company's second board and the twenty-fifth meeting of the second supervisory board will be held on July 18, 2025 [1] - The decision to postpone the project was made after careful research and analysis [1] - The project affected is the "Minglida Jiangxi Xinfeng Precision Structural Components Production Base Construction Project (Phase I)" [1]

Summary of Key Points Core Viewpoint - The company, Zhejiang Shibao Co., Ltd., has decided to postpone certain fundraising investment projects due to the actual net amount raised being lower than initially planned, which aims to enhance the efficiency and safety of fund usage [1][2][5]. Group 1: Fundraising Overview - The company raised a total of RMB 344,087,745.02 through a specific stock issuance, with an issuance price of RMB 10.61 per share for 32,987,747 shares [1][2]. - The net amount raised is lower than the intended investment amount for the projects [2]. Group 2: Fund Management - The company has established a management system for the raised funds, ensuring they are stored in a dedicated bank account and managed according to relevant regulations [3][4]. - A tripartite agreement has been signed with the underwriting institution to clarify the rights and obligations of all parties involved in the fund management [3]. Group 3: Project Postponement Details - The company plans to extend the completion date of the "Intelligent Connected Vehicle Steering Control Technology R&D Center Project" to June 30, 2026, to adapt to market changes and enhance its R&D capabilities [4][6]. - The adjustments made to the project do not alter the intended use of the raised funds [4][6]. Group 4: Approval Process - Both the board of directors and the supervisory board have approved the postponement of the fundraising investment projects, affirming that it aligns with the company's development needs and benefits all shareholders [5][6]. - The underwriting institution has no objections to the postponement, confirming that it will not adversely affect the company's normal operations [6].